Clinical trial
Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes…
NCT00115570 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00115570 |
|---|---|
| Title | Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents |
| Official title | Efficacy and Safety of Insulin Glulisine Compared With Insulin Lispro in Children and Adolescents With Type 1 Diabetes Mellitus: A 26 Week, Multicenter, Open, Parallel Clinical Trial |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Insulin-Dependent |
| Intervention type | Drug |
| Interventions | Insulin glulisine, insulin lispro, insulin glargine, NPH insulin |
| Enrollment | 572 |
| Start date | Apr 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Jun 24, 2005 |
| Last update posted | May 20, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: